NCT02300532已完成不适用
Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 561
- 主要终点
- Number of Adverse Events/Serious Adverse Events
研究概览
简要总结
Post-marketing surveillance to investigate the clinical safety and effectiveness in patients of all implantation of Gliadel with malignant glioma in the actual medical setting.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Number of Adverse Events/Serious Adverse Events
时间窗: Up to 3 months
次要结局
- Survival rate(Up to 1 year)
研究者
相似试验
未知
Unknown
All-case observational study of Gliadel(Study: GLI01S)malignant gliomaJPRN-jRCT1080222547Eisai Co., Ltd.250
撤回
不适用
A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisRheumatoid ArthritisAnkylosing SpondylitisPsoriatic ArthritisNCT01692457Janssen Pharmaceutica
已完成
不适用
A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Intense StrongJawline Contour DeficitNCT06562075Bohus Biotech AB114
已完成
不适用
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)Arthritis, RheumatoidSpondylitis, AnkylosingArthritis, PsoriaticPsoriasisCrohn's DiseaseNCT00727298Merck Sharp & Dohme LLC4,485
已完成
不适用
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)GlioblastomaGliomaAstrocytomaNCT00723827Merck Sharp & Dohme LLC682